ANTX insider receives 2,283 shares in stock awards
By AlphaYouPublished Form 4
Marks Gilbert Lynn
Reporting filer
Marks Gilbert Lynn reported 2,283 shares of Common Stock in AN2 Therapeutics, Inc. as grants or awards dated 2026-10-12. The Form 4 was disclosed on Oct 13, 2026. These were stock awards, not open-market purchases.
- Disclosed
- Oct 13, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Marks Gilbert Lynn | 2026-10-12 | A | Grant or award | 2283 | 0 | 84,156 | 1 day | Filed terms
|
Common Stock
- Owner
- Marks Gilbert Lynn
- Date
- 2026-10-12
- Code
- A
- Action
- Grant or award
- Quantity
- 2283
- Price
- 0
- Following holdings
- 84,156
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-12
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 2283
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 84156
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Marks Gilbert Lynn: Director.
- F1: Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.
Original sources
Prepared automatically from public filing data. Report a correction.